retatrutide phase 3 2025 triple agonist glp-1 gip glucagon Lilly's achieves 16.8% weight loss in trial What Is Retatrutide? The Triple

This has led to pharmacies and companies selling their own versions of this medication

Currently, both domestic and international studies have investigated the correlations between GLP-1RAs and medullary thyroid cancer, pancreatic cancer, colorectal cancer, prostate cancer, breast cancer, reproductive system tumors, and other oncological disorders

Chu, L., Bradley, R

Some people regain weight if habits are not in place

Another study showed that the impact of tirzepatide on weight loss was greater than semaglutide in adults who are overweight or obese, demonstrating different effects in comparison to the breast cancer population [90]

The brands are Mounjaro, injected once a week (FDA approved for Type 2 DM) Zepbound, injected once weekly (FDA approved for weight management)